We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
NN Inc
NNBR
$237M
| $94.6K | ﹤0.01% |
73,920
+16,732
| +29% | +$25.6K |
|
|
XNET
2652
Xunlei
XNET
$333M
| $94K | ﹤0.01% |
13,255
-12,063
| -48% | -$96.8K |
|
|
VALN
2653
Valneva
VALN
$518M
| $93.8K | ﹤0.01% |
+10,634
| New | +$98.7K |
|
2654
Smart Sand
SND
$179M
| $93.6K | ﹤0.01% |
+23,409
| New | +$66.2K |
|
|
ODV
2655
DELISTED
Osisko Development Corp
ODV
| $93.3K | ﹤0.01% |
26,741
-152,967
| -85% | -$526K |
|
2656
ESS Tech
GWH
$21M
| $93.3K | ﹤0.01% |
49,609
+28,749
| +138% | +$91.4K |
|
2657
Hyliion Holdings
HYLN
$578M
| $93.2K | ﹤0.01% |
+50,635
| New | +$102K |
|
2658
CareCloud
CCLD
$103M
| $92.5K | ﹤0.01% |
31,685
-26,236
| -45% | -$83K |
|
|
KLRS
2659
Kalaris Therapeutics
KLRS
$80.9M
| $92K | ﹤0.01% |
+10,897
| New | +$69.7K |
|
2660
Shattuck Labs
STTK
$646M
| $90.8K | ﹤0.01% |
24,873
-1,353
| -5% | -$3.23K |
|
2661
Cingulate
CING
$61M
| $90K | ﹤0.01% |
+20,742
| New | +$80.1K |
|
2662
CVRx
CVRX
$131M
| $89.9K | ﹤0.01% |
+12,657
| New | +$116K |
|
2663
Indonesia Energy Corp
INDO
$44.2M
| $89.6K | ﹤0.01% |
+30,574
| New | +$87.8K |
|
|
AHRT
2664
AH Realty Trust
AHRT
$536M
| $88.8K | ﹤0.01% |
+13,413
| New | +$88.5K |
|
|
ALAR
2665
Alarum Technologies
ALAR
$12.5M
| $88.6K | ﹤0.01% |
10,331
-4,998
| -33% | -$59.9K |
|
|
TLX
2666
Telix Pharmaceuticals
TLX
$3.42B
| $88.5K | ﹤0.01% |
+11,820
| New | +$114K |
|
2667
Ultralife
ULBI
$88.3M
| $88.4K | ﹤0.01% |
15,456
+2,569
| +20% | +$15.8K |
|
|
MAPS
2668
DELISTED
WM TECHNOLOGY INC A
MAPS
| $88.1K | ﹤0.01% |
106,800
-62,139
| -37% | -$61.2K |
|
|
MRCC
2669
DELISTED
Monroe Capital Corp
MRCC
| $88.1K | ﹤0.01% |
+13,827
| New | +$91.8K |
|
2670
Karyopharm Therapeutics
KPTI
$155M
| $87.6K | ﹤0.01% |
11,904
-2,498
| -17% | -$15.3K |
|
2671
Nano X Imaging
NNOX
$61.1M
| $87.3K | ﹤0.01% |
31,192
-2,942
| -9% | -$10.6K |
|
|
SRG
2672
Seritage Growth Properties
SRG
$138M
| $87.1K | ﹤0.01% |
+26,812
| New | +$102K |
|
2673
Crescent Energy
CRGY
$3.65B
| $86.6K | ﹤0.01% |
10,322
-50,256
| -83% | -$441K |
|
2674
Novavax
NVAX
$1.21B
| $86.5K | ﹤0.01% |
12,871
-119,332
| -90% | -$900K |
|
2675
Marker Therapeutics
MRKR
$18.5M
| $86.5K | ﹤0.01% |
58,041
+36,269
| +167% | +$41.1K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.